|
Quotes & Info
|
| SIGA > SEC Filings for SIGA > Form 8-K on 13-Mar-2013 | All Recent SEC Filings |
13-Mar-2013
Other Events, Financial Statements and Exhibits
On March 12, 2013, SIGA Technologies, Inc., a Delaware corporation ("SIGA"), issued a press release announcing the delivery of approximately 190,000 courses of its proprietary smallpox antiviral drug, Arestvyr™, to the United States Government's Strategic National Stockpile. This delivery is the first of a series of deliveries of Arestvyr™ pursuant to SIGA's contract with the Biomedical Advanced Research and Development Authority.
(c) Exhibits
Exhibit No. Description
99.1 Press Release, dated March 12, 2013
|
|